Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Schlessinger

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2012
Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrateByung Hak Ha, Matthew J Davis, Catherine Chen, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Inducible FAK Deletion but not FAK Inhibition in Endothelial Cells Activates p53 to Suppress Tumor Growth in PYK2-null MiceXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Journal of Medicinal Chemistry|June 2, 2022
Insights on JAK2 Modulation by Potent, Selective, and Cell-Permeable Pseudokinase-Domain LigandsMaria-Elena Liosi, Joseph A Ippolito, Sean P Henry, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanismsXiarong Shi, Valia T Mihaylova, Leena Kuruvilla, et al.
Molecular Cell|July 21, 2004
A glutamine switch mechanism for nucleotide selectivity by phosphodiesterasesKam Y J Zhang, Graeme L Card, Yoshihisa Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2020
Scaffold association factor B (SAFB) is required for expression of prenyltransferases and RAS membrane associationMo Zhou, Leena Kuruvilla, Xiarong Shi, et al.
Nature Biotechnology|February 3, 2005
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug designGraeme L Card, Landy Blasdel, Bruce P England, et al.
Structure (London, England : 1993)|December 4, 2004
Structural basis for the activity of drugs that inhibit phosphodiesterasesGraeme L Card, Bruce P England, Yoshihisa Suzuki, et al.
Nature|November 25, 2021
Structural basis for ligand reception by anaplastic lymphoma kinaseTongqing Li, Steven E Stayrook, Yuko Tsutsui, et al.
Nature Genetics|July 28, 2015
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomasMichael Krauthammer, Yong Kong, Antonella Bacchiocchi, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2012
Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrateByung Hak Ha, Matthew J Davis, Catherine Chen, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Inducible FAK Deletion but not FAK Inhibition in Endothelial Cells Activates p53 to Suppress Tumor Growth in PYK2-null MiceXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Journal of Medicinal Chemistry|June 2, 2022
Insights on JAK2 Modulation by Potent, Selective, and Cell-Permeable Pseudokinase-Domain LigandsMaria-Elena Liosi, Joseph A Ippolito, Sean P Henry, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanismsXiarong Shi, Valia T Mihaylova, Leena Kuruvilla, et al.
Molecular Cell|July 21, 2004
A glutamine switch mechanism for nucleotide selectivity by phosphodiesterasesKam Y J Zhang, Graeme L Card, Yoshihisa Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2020
Scaffold association factor B (SAFB) is required for expression of prenyltransferases and RAS membrane associationMo Zhou, Leena Kuruvilla, Xiarong Shi, et al.
Nature Biotechnology|February 3, 2005
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug designGraeme L Card, Landy Blasdel, Bruce P England, et al.
Structure (London, England : 1993)|December 4, 2004
Structural basis for the activity of drugs that inhibit phosphodiesterasesGraeme L Card, Bruce P England, Yoshihisa Suzuki, et al.
Nature|November 25, 2021
Structural basis for ligand reception by anaplastic lymphoma kinaseTongqing Li, Steven E Stayrook, Yuko Tsutsui, et al.
Nature Genetics|July 28, 2015
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomasMichael Krauthammer, Yong Kong, Antonella Bacchiocchi, et al.
Pageof 13